Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

NCT01997411 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Nasal Glucagon
DRUG: Intramuscular Glucagon

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]